SOLIGENIX, INC. (SNGX) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Soligenix, Inc. on August 15, 2025. The Company is a small business issuer incorporated in Delaware with principal executive offices in Princeton, NJ. Its common stock trades on The Nasdaq Capital Market under the symbol "SNGX".
Key Financial Metrics and Liquidity
The filing addresses the Company's compliance with Nasdaq Listing Rule 5550(b)(1), which requires a minimum stockholders' equity of $2,500,000.
- Reported Stockholders' Equity: $1,828,951 (as of June 30, 2025, per Form 10-Q).
- Recent Capital Raise: Approximately $1,439,300 in gross proceeds from an At-The-Market ("ATM") facility sale on July 1, 2025.
- Compliance Status: The reported equity of $1,828,951 is below the $2,500,000 requirement. The filing notes this amount does not yet reflect the July 1 ATM proceeds.
- Alternative Standards: The Company does not meet alternative listing standards for market value of listed securities ($35 million) or net income ($500,000).
The filing does not provide specific data on revenue, operating profit, cash flow, or debt levels for the current period.
Material Changes and Events
On August 15, 2025, the Company received a formal Notice from Nasdaq advising it is not in compliance with the minimum stockholders' equity requirement. This notice has no immediate effect on the listing, and the stock continues to trade under the symbol "SNGX".
Outlook, Risks, and Management Commentary
Compliance Timeline:
- Plan Submission: The Company has 45 calendar days (until September 29, 2025) to submit a plan to regain compliance.
- Extension: If the plan is accepted, Nasdaq may grant an extension of up to 180 calendar days to evidence compliance.
Management Action: The Company is evaluating various courses of action to regain compliance and intends to submit a plan timely.
Risks and Contingencies:
- There is no assurance that the Company's plan will be accepted or that it will successfully regain compliance.
- Failure to regain compliance within the allowed timeframe or failure to satisfy other listing requirements could result in delisting.
- The Company retains the right to appeal a delisting determination to a Nasdaq Hearings Panel, which would stay any suspension pending the hearing.
Investor Verification Checklist
- Verify the updated stockholders' equity balance after incorporating the July 1, 2025 ATM proceeds to determine if the $2.5 million threshold is met.
- Monitor the submission of the compliance plan to Nasdaq by the September 29, 2025 deadline.
- Review the Company's Form 10-K for the year ended December 31, 2024, for detailed risk factors and historical financial performance.
- Assess the likelihood of the Company meeting alternative listing standards (market value or net income) if the equity requirement remains unmet.